The DOI matches its Crossref record.
Benzodiazepine Antagonist Ro 15–1788: Binding Characteristics and Interaction with Drug‐Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels
Abstract
Abstract: The recently discovered benzodiazepine antagonist Ro 15‐1788 was characterized in binding studies, and its potency and selectivity were determined in vivo by interaction with drug‐induced changes in dopamine turnover and cerebellar cGMP level. Ro 15‐1788 reduced [3 H]flunitrazepam binding in the brain in vivo with a potency similar to that of diazepam and effectively inhibited [3 H]diazepam binding in vitro (IC 50= 2.3 ± 0.6 nmol/liter). [3 H]Ro 15‐1788 bound to tissue fractions of rat cerebral cortex with an apparent dissociation constant (KD) of 1.0 ± 0.1 nmol/liter. The in vitro potency of various benzodiazepines in displacing [3 H]Ro 15‐1788 from its binding site was of the same rank order as found previously in [3 H]diazepam binding. Autoradiograms of [3 H]Ro 15‐1788 binding in sections of rat cerebellum showed the same distribution of radioactivity as with [3 H]flunitrazepam. The attenuating effect of diazepam on the chlorpromazine‐ or stress‐induced elevation of homovanillic acid in rat brain was antagonized by Ro 15‐1788. Among a series of compounds which either decreased or increased the rat cerebellar cGMP level, only the effect of benzodiazepine receptor ligands (diazepam, zopiclone, CL 218 872) was antagonized by Ro 15‐1788. Thus, Ro 15‐1788 is a selective benzodiazepine antagonist acting at the level of the benzodiazepine receptor in the central nervous system. Peripheral benzodiazepine binding sites in kidney and schistosomes were not affected by Ro 15‐1788.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hevers, W., & Lüddens, H. (1998) · Molecular Neurobiology · doi:10.1007/bf02741459 · Cited by 489
Drug interactions at GABAA receptors
Korpi, E. R., Gründer, G., & Lüddens, H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00013-8 · Cited by 473
Agonist and antagonist benzodiazepine receptor interaction in vitro
Möhler, H., & Richards, J. G. (1981) · Nature · doi:10.1038/294763a0 · Cited by 381
Self-citationPolc, P., Bonetti, E. P., Schaffner, R., & Haefely, W. (1982) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00498510 · Cited by 314
Self-citationTime course for development of benzodiazepine tolerance and physical dependence
Rosenberg, H. C., & Chiu, T. H. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90038-7 · Cited by 90
Metadata
- Authors
- Möhler, H., Burkard, W. P., Keller, H. H., Richards, J. G., & Haefely, W.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1982-09
- Volume
- 37
- Issue
- 3
- Pages
- 714-722
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1991861023
- Cited by
- 222
- References
- 0
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepine Antagonist Ro 15–1788: Binding Characteristics and Interaction with Drug‐Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels. https://app.cochat.ai/papers/10.1111/j.1471-4159.1982.tb12546.x
- The paper
- Möhler, H., Burkard, W. P., Keller, H. H., Richards, J. G., & Haefely, W. (1982). Benzodiazepine Antagonist Ro 15–1788: Binding Characteristics and Interaction with Drug‐Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1982.tb12546.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.